Lynkuet (ceritinib): Patient Guide
Lynkuet is the brand name for ceritinib, a targeted cancer medicine taken by mouth. It is used to treat advanced non-small cell lung cancer that has tested positive for an ALK gene change.
Lynkuet can slow or stop the growth of ALK-positive lung cancer, but it requires regular monitoring for side effects. Take it only as prescribed and contact your oncology team if you develop breathing problems, severe diarrhea, or signs of liver injury.
Key facts at a glance
- RxNorm
- 2725517
- Generic
- Lynkuet
- Class
- brand-name
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy